In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews from March 2011.

Pharmaceutical Technology
Volume 35, Issue 3, pp. 24

Editors' Picks of Pharmaceutical Science & Technology Innovations

Automation has become increasingly important to the pharmaceutical industry, partly because it can enhance product quality and reduce the occurrence of deviations. Many vendors provide devices intended to control manufacturing and quality-assurance operations, and drugmakers have come to rely on these innovations. This month's products are intended for various process-control applications. The new model of Stratophase's data-monitoring unit helps indicate process status. Two of Shimadzu's gas-chromatography instruments now can be controlled through Waters's Empower 2 software. A pressure logger is the latest addition to Mesa Laboratories's series of process-validation systems.

Data-monitoring unit offers process control


Benchtop data-monitoring unit Stratophase www.stratophase.com
The new model of Stratophase's benchtop data-monitoring unit lets personnel track eight independent SpectroSens probes simultaneously and has a smaller footprint than the previous model did. The new machine includes a built-in touch-screen monitor that eliminates the need for a separate monitor, keyboard, or mouse. Users can implement the benchtop data-monitoring unit as stand-alone process-monitoring and data-analysis system, or network it with other process-control equipment as part of a process-management system. The probes' optical microchip sensor technology offers measurements that can indicate process status and product quality.

Stratophase's data-monitoring unit uses temperature-compensated refractive index as a measurement of concentration, thus providing information that can be used to control a process directly. Personnel can use the data gathered by Stratophase's system to profile the process and compare real-time data to a historical process model.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here